• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.69% Nasdaq Up2.12%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NMS
    410.99 14.86(3.75%) Dec 17, 4:00PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income 424,362   750,269   (221,760)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation41,204  36,940  31,082  
    Adjustments To Net Income308,751  (189,025)67,909  
    Changes In Accounts Receivables(198,658)(590,085)(21,118)
    Changes In Liabilities108,710  (30,098)9,687  
    Changes In Inventories(47,956)(28,932)(14,094)
    Changes In Other Operating Activities(52,765)(23,684)6,612  
    Total Cash Flow From Operating Activities 583,648   (74,615) (141,682)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(156,323)(49,337)(57,217)
    Investments(199,132)(31,184)185,965  
    Other Cash flows from Investing Activities -  (552)(277)
    Total Cash Flows From Investing Activities (355,455) (81,073) 128,471  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock57,393  63,549  137,387  
    Net Borrowings(2,024)(2,203)389,440  
    Other Cash Flows from Financing Activities(195,087)(163,300)(25,078)
    Total Cash Flows From Financing Activities 77,139   (97,646) 384,249  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 305,332   (253,334) 371,038  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.